MDx assay design and development using real-time PCR

Jan. 18, 2024
The growing demand for MDx assays warrants the need for fast and accurate workflows that reduce the cost and time to bring a new assay to market.

Real-time PCR–based molecular diagnostics enable fast sample-to-result times and sensitive target detection and quantification.  The QuantStudio Dx family of real-time PCR systems from Thermo Fisher Scientific provides an accurate, reliable, and IVD-ready platform for streamlining MDx assay development. This white paper introduces our product and service ecosystem designed with the following in mind: high-quality and accurate results, consistent manufacturing standards and performance of reagents, and in vitro diagnostics (IVD) compliance and support.


This is sponsored by: